Jeff Ajer
2021
Compensation breakdown
| Non-Equity Incentive Plan | $567,300 |
|---|---|
| Option Awards | $841,896 |
| Salary | $610,000 |
| Stock Awards | $2,941,280 |
| Other | $24,933 |
| Total | $4,985,408 |
Ajer received $2.9M in stock awards, accounting for 59% of the total pay in 2021.
Ajer also received $567.3K in non-equity incentive plan, $841.9K in option awards, $610K in salary and $24.9K in other compensation.
Rankings
In 2021, Jeff Ajer's compensation ranked 2,631st out of 12,397 executives tracked by ExecPay. In other words, Ajer earned more than 78.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,631 out of 12,397 | 79th |
Division Manufacturing | 1,039 out of 5,492 | 81st |
Major group Chemicals And Allied Products | 404 out of 2,367 | 83rd |
Industry group Drugs | 354 out of 2,090 | 83rd |
Industry Pharmaceutical Preparations | 231 out of 1,537 | 85th |
Pay ratio
| Jeff Ajer's Pay | $4,985,408 |
|---|---|
| Median Employee's Pay | $175,523 |
| Pay Ratio | 28to 1 |
In 2021, the annual total compensation of Jeff Ajer was $4,985,408.
The annual total compensation of the median employee at BioMarin Pharmaceutical was $175,523.
The ratio of Jeff Ajer's pay to the pay of median employee was therefore 28 to one.
Ajer's colleagues
We found four more compensation records of executives who worked with Jeff Ajer at BioMarin Pharmaceutical in 2021.
2021
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
2021
Henry Fuchs
BioMarin Pharmaceutical
President, Worldwide R&D
2021
C Guyer
BioMarin Pharmaceutical
Chief Technical Officer and Executive Vice President of Global Manufacturing and Technical Operations
2021
Brian Mueller
BioMarin Pharmaceutical
Chief Financial Officer
News
April 12, 2022
April 13, 2021
April 14, 2020
April 23, 2019